Avatar-led Acceptance and Commitment Therapy Smoking Cessation (Flexiquit)

August 17, 2018 updated by: Maria Karekla, University of Cyprus

An Avatar-led Acceptance and Commitment Therapy Intervention Promotes Smoking Cessation in Young Adults

Smoking remains a global concern, especially for youth where developmentally-suited smoking cessation programs are lacking and especially among those not presenting for treatment on their own. We aimed to assess the effectiveness of an avatar-led digitalized smoking cessation intervention (Flexiquit) based on Acceptance and Commitment Therapy (ACT) for young adult smokers at all levels of motivation to quit.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Detailed Description

Cigarette smoking is associated with various health problems, particularly certain forms of cancer and early death (Centers for Disease Control and Prevention, 1997). More recently, smoking has become a global problem among youth and it is imperative that research puts an emphasis on prevention and intervention particularly in this age group (World Health Organization, 2009). Over the past few years, research has shown that internet-based interventions are more cost effective, cater to individuals who are unable/unwilling to attend weekly treatment sessions with a therapist, and are promising in terms of improving attrition rates, a major problem with most treatment trials. Moreover, internet-based interventions use technology often utilized to attract youth (interactive games, animation, video clips etc.) and thus may reach and engage a wider range of individuals than traditional face-to-face interventions. ACT is an empirically-based intervention that uses acceptance and mindfulness strategies and has been shown to increase psychological flexibility. The aim of the present study is to investigate the usefulness and effectiveness of an Acceptance and Commitment Therapy (ACT) internet-based smoking cessation intervention program for college, high school and vocational school student smokers. Findings are expected to show that a digitalized program designed to engage youth in smoking cessation can result in quitting smoking and has a high applicability potential especially among the hard-to-reach population of youth.

Study Type

Interventional

Enrollment (Anticipated)

300

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Non-US/Non-Canadian
      • Nicosia, Non-US/Non-Canadian, Cyprus, 1678
        • Recruiting
        • University of Cyprus

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

15 years to 30 years (Child, Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Regular smoker (at least 1 cigarette per day)
  • Parental consent for those under 18years of age

Exclusion Criteria:

  • Currently enrolled in another smoking cessation program

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Waitlist control
Wait-list control group
Experimental: Flexiquit
Digital ACT-based intervention for smoking cessation
Digital avatar-led Acceptance and Commitment Therapy for smoking cessation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quit rate
Time Frame: Post-intervention (following completion of digital session 5) and follow-up (3 months and 6 months after post-intervention)
Change in Smoking quit status at each assessment point
Post-intervention (following completion of digital session 5) and follow-up (3 months and 6 months after post-intervention)
Change in Number of cigarettes
Time Frame: Post-intervention (following completion of digital session 5) and follow-up (3 months and 6 months after post-intervention)
Change in the number of cigarettes smoked per day
Post-intervention (following completion of digital session 5) and follow-up (3 months and 6 months after post-intervention)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Nicotine Dependence
Time Frame: Post-intervention (following completion of digital session 5) and follow-up (3 months and 6 months after post-intervention)
Change in the Fagerstrom Test of Nicotine Dependence scores
Post-intervention (following completion of digital session 5) and follow-up (3 months and 6 months after post-intervention)
Change in Readiness to quit
Time Frame: Post-intervention (following completion of digital session 5) and follow-up (3 months and 6 months after post-intervention)
Change in the Contemplation Ladder assessing stages of change
Post-intervention (following completion of digital session 5) and follow-up (3 months and 6 months after post-intervention)
Change in self-efficacy to not smoke in specific situations
Time Frame: Post-intervention (following completion of digital session 5) and follow-up (3 months and 6 months after post-intervention)
Change in Smoking Self-Efficacy Questionnaire scores
Post-intervention (following completion of digital session 5) and follow-up (3 months and 6 months after post-intervention)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 15, 2017

Primary Completion (Anticipated)

July 30, 2019

Study Completion (Anticipated)

July 30, 2020

Study Registration Dates

First Submitted

August 7, 2018

First Submitted That Met QC Criteria

August 10, 2018

First Posted (Actual)

August 15, 2018

Study Record Updates

Last Update Posted (Actual)

August 21, 2018

Last Update Submitted That Met QC Criteria

August 17, 2018

Last Verified

August 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • ΕΕΒΚ/ΕΠ/2013/05

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Smoking Cessation

3
Subscribe